Abstract
MYH9 disorder is a rare autosomal-dominant disorder. We previously reported that it is caused by mutations in the gene for nonmuscle myosin heavy chain IIA (NMMHC-IIA). MYH9 disorder causes congenital macrothrombocytopenia accompanied by progressive sensorineural hearing loss, nephropathy, and cataract. However, there are few reports that describe the audiological features of MYH9 disorder. The objective of this study was to characterize auditory and other phenotypes of patients with MYH9 disorder. We examined nine subjects from one Japanese family. Audiological, ophthalmological, hematological, and imaging examinations were used to assess clinical features. We carried out genetic analysis of the causative gene, MYH9. Five subjects exhibited macrothrombocytopenia and neutrophil cytoplasmic inclusion bodies. Immunofluorescence analysis of neutrophil NMMHC-IIA revealed abnormal type II localization. Two subjects had high-frequency dominant hearing loss, which was adult onset and progressive. Only one subject had cataract. MYH9 sequencing analysis of all thrombocytopenic subjects revealed a heterozygous c.4270G>A mutation in exon 30 (p.D1424N). We identified five patients with MYH9 disorder from the family. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.
Similar content being viewed by others
References
Kunishima S, Kojima T, Matsushita T et al (2001) Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 97:1147–1149
Kunishima S, Saito H (2010) Advances in the understanding of MYH9 disorders. Curr Opin Hematol 17:405–410
Pecci A, Klersy C, Gresele P et al (2014) MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 35:236–247
Mhatre AN, Kim Y, Brodie HA, Lalwani AK (2003) Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9. Otol Neurotol 24:205–209
Kunishima S, Matsushita T, Kojima T et al (2003) Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83:115–122
Emery JM, Little JH (eds) (1979) Phacoemulsification and aspiration of cataracts: surgical techniques, complications, and results. CV Mosby, St. Louis, pp 45–48
Lalwani AK, Goldstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN (2000) Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 67:1121–1128
Verver E, Pecci A, De Rocco D et al (2015) R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. Clin Genet 88:85–89
Saposnik B, Binard S, Fenneteau O et al (2014) Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-related disorders. Mol Genet Genomic Med 2:297–312
Brodie HA, Chole RA, Griffin GC et al (1992) Macrothrombocytopenia and progressive deafness: a new genetic syndrome. Am J Otol 13:507–511
Acknowledgments
We thank Mr. Koichi Yamaguchi, who belongs to the Department of Clinical Laboratory Center of the Japanese Red Cross Shizuoka Hospital for blood sampling and analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported by a Grant-in-Aid for Clinical Research from the National Hospital Organization (H24-NHO-02).
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wasano, K., Matsunaga, T., Ogawa, K. et al. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder. Eur Arch Otorhinolaryngol 273, 3547–3552 (2016). https://doi.org/10.1007/s00405-016-3954-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-3954-0